Über das Unternehmen
- Firmenname (rechtlich): Viwit Pharmaceutical Co., Ltd.
- Internationaler Name: 维威制药 (Viwit Pharmaceutical Co., Ltd.), China
- Marke / Handelsname: Viwit
- Registrierungsland: China
Beschreibung:
Viwit Pharmaceutical Co., Ltd., established in 2006, manufactures pharmaceutical intermediates and active pharmaceutical ingredients with a particular specialization in borane- and boron-based reducing reagents, including borane-dimethyl sulfide, borane-THF, borane-pyridine, and various borane-amine complexes, alongside chiral pyrrolidine, piperidine, and indanyl building blocks. Its finished API portfolio includes aprepitant and fosaprepitant dimeglumine, varenicline tartrate, luliconazole, vildagliptin, and the MRI contrast agents gadobutrol monohydrate and gadolinium meglumine. The company offers CRO, CMO, and CDMO contract manufacturing under OEM, ODM, and own-brand arrangements, and sells across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.
Geschäftsaktivitäten
Nahrungsergänzungsmittel & Nutrazeutika
Lieferant
Fertigarzneiformen
Hersteller
Biopharmazeutische Produkte
Biotechnologie-/Biopharmaunternehmen
Pharmazeutische Wirkstoffe (API)
Hersteller
Pharmazeutische Chemikalien
Hersteller
ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch)
Hersteller
Absatzmärkte
- Western Europe: Austria, Belgium, France
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
- Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
Hauptprodukte/-dienstleistungen
- Pharmazeutische Wirkstoffe (API): Gadobutrol monohydrate, Aprepitant, Lifitegrast, Varenicline Tartrate, EFINACONAZOLE, Fosaprepitant dimeglumine, Gadolinium meglumine, Luliconazole, Miraberon
- Vertrags- & Outsourcing-Dienstleistungen: Product Development
- Fertigarzneiformen: Finished antibiotic medicines
- Pharmazeutische Chemikalien: (+)-B-Chlorodiisopinocampheylborane, Catecholborane, (R)-(+)-2-(Diphenylhydroxymethyl)pyrrolidine, (S)-(-)-2-(Diphenylhydroxymethyl)pyrrolidine, Borane tetrahydrofuran complex, (R)-(5-Cyano-2, 3-dihydro-1H-inden-1-yl) carbamic acid tert-butyl ester, (R)-tert-Butyl (5-bromo-2, 3-dihydro-1H-inden-1-yl) carbamate(R)-TERT-BUTYL (5-BROMO-2,3-DIHYDRO-1H-INDEN-1-YL)CARBAMATE, (R)-1-Amino -2, 3-dihydro-1H-indene-5-carbonitrile hydrochloride, 1-Methyl-6-boronic acid pinacolyl ester-3,4-dihydroquinoline -2(1H)-one, (1S,2S,3R,5S)-(+)-2,3-Pinanediol, 1-(2-Tetrahydropyranyl)-1H-pyrazole-5-boronic acid ester, 1-(((2R,3S)-2-(2,4-difluorophenyl)-3-methylepoxyethyl-2-yl) methyl)-1H-1,2,4-triazole, 1-BOC-3, 3-Dimethyl-4-oxopiperidine, 1-HYDROXYETHYL ADAMANTANE, [1,1 '-Biphenyl]-4-yl [4-[[1,1'-biphenyl]-4-sulfanyl] phenyl] thioninium-tetrakis (pentafluorophenyl) borate, 1,1-Dimethylethyl 4-hydroxy-4-[(2-methoxyethoxy)methyl]-1-piperidinecarboxylate, 1,2-Bis [(trifluorovinyl) oxy] ethane, 1H-indazole -7-carboxylic acid methyl ester, 1H-indazole-7-carboxamide, (1R,2R,3S,5R)-(-)-2,3-Pinanediol, 2 - methyl -5-- nitroimidazole, 2 '-fluoro -1,1': 4 ', 1'-terphenyl, 2-((1R)-1-AMINOETHYL)-4-FLUOROPHENOL, 2-(2-Amino-5-bromo-benzoyl) pyridine, 2-Chloro-1, 3,2-dioxaphosphine, 2-Chloro-3-fluorophenylboronic acid, 2-Fluoro-6-hydroxyphenylboronic acid pinacol ester, ((2-Fluoro-8-(4,4, 5,5-tetramethyl -1,3, 2-dioxaborolan-2-yl) naphthalen-1-yl) ethynyl) triisopropylsilane, 2-Methylpyridine-N-borane, (2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1, 2,4-triazol-1-yl) butane-2, 3-diol, (2R,3S)-2-[(1R)-1-[3,5-bis (trifluoromethyl) phenyl] ethoxy]-3-(4-fluorophenyl)-morpholine hydrochloride(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride, (2R,3S)-2-[(1R)-1-[3,5-bis (trifluoromethyl) phenyl] ethoxy]-3-(4-fluorophenyl) morpholine p-benzenesulfonate, (3-(9-borabicyclo[3.3.1]nonan-9-yl)propyl)triphenylphosphoniumebromide, 3-acetamidopyrazole, 3-Chloro-5-hydroxybenzonitrile, 3-Fluoro-5-hydroxybenzonitrile, 3-fluoroquinoline -5-borate pinacol ester, 3,5-Difluorobenzonitrile, 4-Bromo-2-fluorobiphenyl, 4-Cyano -1-(2,6-difluorobenzyl)-1H-1,2,3-triazole, 4-Methanesulfonyl-cyclohexyl ketone, 4-Methylene Piperidine Hydrochloride, 5-Bromo-3-fluoroquinoline, 5-chloromethyl-2, 4-dihydro [1,2,4] triazol-3-one, 5-ethyl -2-methyl pyridine borane, 6-Bromo-3-iodo-1-methyl-1H-indazole, 6,6-Dimethyl-3-azabicyclo [3.1.0] hexane-2, 4-dione, 6,6-Dimethyl-3-azabicyclo [3.1.0] hexane, 7-Carboxyl -1H-indazole, 7-Hydroxy-[1,2,4] triazolo [1,5-A] pyridine, 9-Borabicyclo[3.3.1]nonane, Borane-2-picoline complex, Borane-ammonia, borane diethylamine complex, Borane-dimethyl sulfide complex intermediates, Borane-dimethylamine, Borane-N,N-diisopropylethylamine, Borane-pyridine, Borane-tert-butylamine complex, borane triethylamine complex, borane trimethylamine complex, cis-1-BOC-3, 4-dihydroxypyrrolidine, Cis-1-BOC-3-hydroxy-4-methoxypyrrolidine, cis-1-BOC-pyrrolidine-3, 4-diamine, cis-3, 4-dihydroxypyrrolidine hydrochloride, Decafluoro-3-methoxy-2-trifluoromethylpentane, Diethyl (3-Pyridyl) Borane, DOTA intermediates, ethyl 2-acetyl acetate chloride, Ethyl 3-(2-chlorophenoxy)-2-butenoate, FOMC-Glutamic acid -5-methyl ester, Glyoxal -1,1-dimethyl acetal, imidazole -1-yl acetonitrile, Indolo [2,3-A] carbazole, Methyl (3S)-7-bromo-2, 3-dihydro-2-oxo-5-(2-pyridyl)-1H-1, 4-benzodiazepine -3-propionate, Methylboronic acid, N-BOC-Amino-piperidinyl -1,1-carboxylic acid, N-Methyl morpholine borane, N-tert-butyl-1H-indazole-7-carboxamide, N,N-Diethylaniline Borane intermediates, N,N-dihexadecylphenylammonium tetrakis (pentafluorophenyl) borateN,N-dihexadecylanilinium tetrakis(pentafluorophenyl)borate, N,N-Dimethylanilinium tetrakis (pentafluorophenyl) borate, N,N-dioctadecylmethylammonium tetrakis(pentafluorophenyl)borate, Pinacolborane intermediates, Potassium tetrakis (pentafluorophenyl) borate, Propylgallate Injection, Pyridine-2-sulfonyl fluoride, (R)-( )-1-Phenylethanol, (R)-3-(Methoxymethyl) pyrrolidine -1-carboxylic acid ((3S,7aS)-7a-hydroxymethyl-6-(methylene) tetrahydro1H-pyrrorizin-3-yl) methanol ester, (R)-Methyl Oxazaborolidine intermediates, (S)-(-)-1-Phenylethanol, (S)-(-)-1,2, 3,4-tetrahydro-1-naphthoic acid, (S)-2-Amino-5-methoxytetrahydronaphthalene (S)-mandelate, (S)-2-Chloro-1-(2,4-dichlorophenyl), (S)-2-Chloro-1-(2,4-dichlorophenyl) ethyl methanesulfonate, (S)-3-Amino -3-(4-chlorophenyl)-propionic acid, (S)-Methyl Oxazaborolidine intermediates, Sodium tetrakis (pentafluorophenyl) borate, tert-Butyl 1-oxo-6-azospiro [2.5] octane -6-carboxylate, tert-Butyl 2-((4R,6R)-6-(2-(4-fluorophenyl)-4-((4-(hydroxymethyl) phenyl) carbamoyl)-5-isopropyl-3-phenyl-1H-pyrrol-1-yl) ethyl)-2,2-dimethyl-1,3-diox-4-yl) acetate, tert-Butyl 3,3-dimethyl -4-(((trifluoromethyl) sulfonyl) oxy)-3,6-dihydropyridine -1(2H)-carboxylatetert-Butyl 3,3-dimethyl-4-(((trifluoromethyl)sulfonyl)oxy)-3,6-dihydropyridine-1(2H)-carboxylate, tert-Butyl (3S)-3-(4-bromophenyl) piperidine-1-carboxylatetert-butyl (S)-3-(4-bromophenyl)piperidine-1-carboxylate, tert-Butyl trans-(3R,4R)-3,4-diaminopyrrolidine-1-carboxylate, tert-Butyl trans-(3S,4S)-3,4-diaminopyrrolidine-1-carboxylate, Tetrabenzyl pyrophosphate, Triethylboron -1,3-propanediamine, Triethylboron -1,6-hexanediamine, Trimethylboroxine, Triphenylcarbon tetrakis (pentafluorophenyl) borate
- ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch): Vildagliptin, Aceglutamide Injection
Unsere Produkte & Dienstleistungen
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Laboratory Chemicals, Solvents & Reference Standards
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Certifications
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen